-The Financial Express Besides better yield, mechanisation leads to a rise in labour employment India is known as the land of agriculture, with a holding of nearly 157 million hectares of cultivable land, making our country the second-largest agricultural landholder in the world. With over 58% of the country's population depending on agriculture for earning livelihood, it is also the biggest employment avenue in the country. The Indian Green Revolution is regarded as...
More »SEARCH RESULT
The business of ‘creating’ a male child -Ruhi Kandhari
-Tehelka The government has failed to implement the law and stop the use of ART for determining the sex of unborn children. On 14 February 2003, the term ‘pre-conception' was added to the title of the law that prohibited couples and doctors from determining the sex of an unborn child. The new version of the law came to be known as the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act. The amendment...
More »16 newborn die in a week at Chhattisgarh hospital
-The Indian Express Raipur (Chhattisgarh): Mani Sahu's first baby, born at Bilaspur's Chhattisgarh Institute of Medical Sciences Saturday, did not survive even 72 hours. He was among 16 infants who died within days of birth in the last week at CIMS. While some had low birthweight, others died due to lack of medicare facilities. However, while the number of babies admitted in the hospital continues to go up and the child ward...
More »‘Napkin man’ on a mission to empower women -R Ramabhadran Pillai
-The Hindu Kochi (Kerala): Majority of women in India do not use sanitary napkin because of the high cost of the product, says Arunachalam Muruganantham, an entrepreneur who was named one of the 100 most influential persons by Time magazine last year. The school dropout who started his life as a welder at Pudur in rural Coimbatore, has revolutionised the sanitary napkin making industry by developing an innovative Machine that costs less...
More »Why do Indian health authorities keep quiet on pharma firms' failings? -Nivedita Mookerji
-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...
More »